Inspire Medical Systems, Inc.
- Jurisdiction
United States - LEI
549300XQQCQ7HCJKTW25 - ISIN
US4577301090 (INSP )- Sectors
Scores
- Fair value (Benjamin Graham formula)
-
€77.06 15.7% undervalued - Financial strength (Piotroski F-Value)
-
6
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
4
/ 7
Profile
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. Read full profile
Fundamentals
- Net revenue
€734.66M - Gross margin
84.5% - EBIT
€35.31M - EBIT margin
4.8% - Net income
€45.31M - Net margin
6.2%
Statement period: - (published )
Estimates
| Fiscal Year | Net revenue | Net income |
|---|---|---|
|
|
| |
|
|
| |
|
|
|
Stock price
Dividends
- Last dividend amount
-
$9.00 - Ex date
-
Analyst ratings
No analyst ratings available
Insider Transactions
| Name | Title | Transaction Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Buchholz Richard | Chief Financial Officer |
|
|
|
|
Investor transactions
| Name | Shares | Value | Last change | Change type |
|---|---|---|---|---|
| James Anderson |
|
|
|
Sell |
| Peter Brown |
|
|
|
Buy |
| Ray Dalio |
|
|
|
Buy |